These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38555280)

  • 21. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.
    Tarantelli C; Gaudio E; Arribas AJ; Kwee I; Hillmann P; Rinaldi A; Cascione L; Spriano F; Bernasconi E; Guidetti F; Carrassa L; Pittau RB; Beaufils F; Ritschard R; Rageot D; Sele A; Dossena B; Rossi FM; Zucchetto A; Taborelli M; Gattei V; Rossi D; Stathis A; Stussi G; Broggini M; Wymann MP; Wicki A; Zucca E; Cmiljanovic V; Fabbro D; Bertoni F
    Clin Cancer Res; 2018 Jan; 24(1):120-129. PubMed ID: 29066507
    [No Abstract]   [Full Text] [Related]  

  • 23. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
    Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
    Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
    Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
    J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.
    Chiarini F; Falà F; Tazzari PL; Ricci F; Astolfi A; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2009 Apr; 69(8):3520-8. PubMed ID: 19351820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
    Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
    Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway.
    Lin YT; Wang HC; Hsu YC; Cho CL; Yang MY; Chien CY
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Zhang W; Li L; Guo E; Zhou H; Ming J; Sun L; Hu G; Zhang L
    Head Neck; 2022 Jul; 44(7):1576-1587. PubMed ID: 35394102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.
    Li X; Liu H; Wang J; Qin J; Bai Z; Chi B; Yan W; Chen X
    Phytother Res; 2018 Nov; 32(11):2214-2225. PubMed ID: 30069933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma.
    Zhang J; Jiang Y; Yu Y; Li J
    Eur J Pharmacol; 2022 Jan; 915():174688. PubMed ID: 34883074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K-PKB-mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis.
    Yu JH; Chen L; Yu JY; Luo HQ; Wang L
    J Cell Biochem; 2019 Jun; 120(6):10186-10194. PubMed ID: 30582216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
    Zhang J; Zhou J; Xiao S
    Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells.
    Yang K; Tang XJ; Xu FF; Liu JH; Tan YQ; Gao L; Sun Q; Ding X; Liu BH; Chen QX
    Oncol Rep; 2020 Mar; 43(3):773-782. PubMed ID: 32020210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.
    Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT
    Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.
    Awasthi N; Yen PL; Schwarz MA; Schwarz RE
    J Cell Biochem; 2012 Mar; 113(3):784-91. PubMed ID: 22020918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.